Soru

Zorluk: OrtaMonitoring and Treatment Evaluation

A 7272-year-old man with a history of small cell lung cancer is brought to the emergency department after a witnessed generalized tonic-clonic seizure. His family reports that he has been progressively confused and lethargic over the past 33 days. On arrival, he is postictal but protecting his airway. His vital signs are within normal limits. Laboratory studies reveal:

* Serum sodium: 112112 mEq/L
* Serum potassium: 4.04.0 mEq/L
* Serum osmolality: 240240 mOsm/kg
* Urine osmolality: 600600 mOsm/kg
* Urine sodium: 5050 mEq/L

Arrange the following steps in the correct chronological sequence for the acute management and ongoing monitoring of this patient's condition.

  1. 1Administer a 100100 to 150150 mL intravenous bolus of 3%3\% hypertonic saline.
  2. 2Re-evaluate clinical status and repeat the hypertonic saline bolus if seizures persist.
  3. 3Measure serum sodium levels every 22 hours to closely track the rate of correction.
  4. 4Discontinue the hypertonic saline infusion once serum sodium has increased by 44 to 66 mEq/L.
  5. 5Implement strict fluid restriction and initiate disease-directed therapy for the underlying malignancy.

Cevap

The correct sequence begins with the immediate administration of a hypertonic saline bolus to treat the active seizure, followed by a clinical reassessment to determine if a repeat bolus is needed. Once stabilized, serum sodium is monitored every 22 hours to ensure safe correction rates, and hypertonic saline is discontinued as soon as the sodium rises by 44 to 66 mEq/L. Finally, long-term management with fluid restriction is initiated.
This sequence represents the standard of care for severe symptomatic hyponatremia. The first step is to administer 3%3\% hypertonic saline to acutely raise the serum sodium and reduce cerebral edema. If severe symptoms like seizures persist, the bolus should be repeated immediately. Once the patient is stabilized, serum sodium must be monitored frequently (typically every 22 hours) to evaluate the treatment response and ensure the correction rate does not exceed safe limits. Hypertonic saline must be discontinued once symptoms resolve or the sodium level has risen by 44 to 66 mEq/L, as this is sufficient to reverse life-threatening cerebral edema. Finally, the underlying cause (SIADH due to small cell lung cancer) is managed long-term with fluid restriction and targeted cancer therapy.

Adım Adım Çözüm

1
Immediate Intervention
Administer a rapid bolus of 3%3\% hypertonic saline.
To acutely reduce cerebral edema and halt the seizure activity in a patient with severe, symptomatic hyponatremia.
2
Clinical Reassessment
Repeat the hypertonic saline bolus if seizures continue.
Persistent severe neurological symptoms indicate that the cerebral edema has not been adequately reversed.
3
Close Monitoring
Check serum sodium levels every 22 hours.
To ensure the rate of correction does not exceed the safe limit of 88 mEq/L per 2424 hours, which prevents osmotic demyelination syndrome.
4
Therapy De-escalation
Stop hypertonic saline once sodium rises by 44 to 66 mEq/L.
A 44 to 66 mEq/L rise is generally sufficient to resolve acute cerebral edema; continuing beyond this target drastically increases the risk of overcorrection.
5
Long-term Management
Start fluid restriction and treat the lung cancer.
Addresses the underlying cause, which in this case is the syndrome of inappropriate antidiuretic hormone secretion (SIADH) secondary to small cell lung cancer.

Anahtar Kavram

The management of severe symptomatic hyponatremia requires immediate hypertonic saline to raise serum sodium by 44 to 66 mEq/L to arrest seizures, followed by frequent serial monitoring (every 22 hours) to prevent overcorrection and osmotic demyelination syndrome.
Bu soruyu puanla